title: Clinical importance of grade 2 cellular heart rejection.
authors.forename: A
authors.initials: A
authors.lastname: el-Gamel
authors.forename: H
authors.initials: H
authors.lastname: Doran
authors.forename: A
authors.initials: A
authors.lastname: Rahman
authors.forename: A
authors.initials: A
authors.lastname: Deiraniya
authors.forename: C
authors.initials: C
authors.lastname: Campbell
authors.forename: N
authors.initials: N
authors.lastname: Yonan
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D001706:Biopsy; D004359:Drug Therapy, Combination; D004699:Endocardium / Q000473:pathology; D005260:Female; D006084:Graft Rejection / Q000145:classification* / Q000473:pathology; D016027:Heart Transplantation / Q000473:pathology*; D006439:Hemodynamics / Q000502:physiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D009206:Myocardium / Q000473:pathology; D011379:Prognosis
chemical_list: D007166:Immunosuppressive Agents